PATENT CLAIM ANALYSIS

Application Number: 16085099
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["548", "360100"]

Abstract:
This disclosure relates amide-sulfamide compounds disclosed herein and uses related to CXCR4 inhibition. In certain embodiments, the compounds have formula I, salts, derivatives, and prodrugs thereof wherein, A is a bridging aryl or heterocyclyl and R 1  and R 2  are further disclosed herein. In certain embodiments, the disclosure contemplates pharmaceutical compositions comprising compounds disclosed herein. In certain embodiments, the disclosure relates to methods of treating or preventing CXCR4 related diseases or conditions by administering an effective amount of a compound disclosed herein to a subject in need thereof.

Claim (Index 13):
A method of treating or preventing a viral infection comprising administering pharmaceutical composition comprising a compound of  claim 1  to a subject in need thereof.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.72414
- Patent Class: 548.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15311573', '15750086', '15416964', '13879809', '14239177']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7030367012852742
- 35 USC 102 Novelty (BERT): 0.5182115308242137
- Combined Prediction Score: 0.6845541842391681
- Mean Citation Score: 282.6317180000001
- Max Citation Score: 313.4099700000001
- Similarity Product: 255.8939937717033

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test